// App-Quantinova.ai

e18102 : Reducing VTE event rates in complex abdominal cancer surgery: A retrospective, single institute comparison of dextran vs heparin.

Researchers

Presenter

  • Richard Sleightholm

Principal Investigators

  • John Burt

  • Duncan Watley

  • Steven Wahlmeier

  • Asish Patel

  • Jason M. Foster

Medical Centers

  • University of Nebraska Medical Center, Omaha, NE

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Twist-related protein 1

Drug/Treatment

  • Heparin

  • Dextran 40

  • Dex-HEMA

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved